FinCEN Targets Health Care Fraud and Expands Whistleblower Incentives

FinCEN has sharpened its focus on health care fraud with a new Advisory warning financial institutions about increasingly sophisticated schemes targeting Medicare, Medicaid and other government health care benefit programmes. Released on 30 March 2026, the Treasury measure frames health care fraud not simply as a billing abuse issue, but as a money laundering and national security concern involving organised crime groups and transnational criminal organisations.

The Advisory matters because it pushes banks and other financial institutions to treat suspicious health care payments, provider accounts and reimbursement flows as potential indicators of broader criminal networks. FinCEN says these schemes often involve false claims for nonexistent, exploitative, substandard or unnecessary medical care, with criminal groups using straw owners, shell companies and stolen beneficiary data to secure reimbursements. Once funds are paid out, the proceeds are allegedly moved through the US and international financial systems using wire transfers, digital assets and other laundering methods.

A key theme is the industrialisation of fraud. FinCEN describes how transnational criminal organisations allegedly place non-resident aliens in the US as nominee owners of newly formed or acquired health care providers enrolled in federal or state programmes. Those entities then submit fraudulent reimbursement claims, sometimes with the help of corrupt medical professionals receiving kickbacks or bribes. For compliance teams, that signals a need for closer scrutiny of newly established medical businesses, unusual ownership structures and payment activity that does not align with a provider’s expected operational profile.

The release also highlights a notable rise in reporting. Financial institutions filed 20 per cent more suspicious activity reports related to health care in 2025 than in 2024. Treasury presents that increase as evidence of heightened national attention on fraud, but also stresses that current reporting likely captures only a small portion of the illicit activity linked to health care fraud in the US. That point is significant for firms reviewing their anti-money laundering controls, as it suggests regulatory expectations may continue to rise.

Alongside the Advisory, FinCEN announced a proposed rule to implement a formal whistleblower programme covering fraud, money laundering, sanctions violations and certain other national security laws. Under the proposal, eligible whistleblowers could receive between 10 and 30 per cent of monetary penalties from qualifying enforcement actions. Funding would come from penalties collected under the Bank Secrecy Act and the International Emergency Economic Powers Act in actions brought by Treasury and the Department of Justice.

That second announcement is strategically important. It suggests Treasury is building a stronger pipeline for insider reporting at the same time as it asks financial institutions to improve external detection. In practice, that creates a two-track enforcement model: banks are expected to identify and report red flags, while individuals with actionable information are given a direct financial incentive to come forward. For firms operating in health care payments, sanctions-sensitive sectors or complex cross-border financial flows, that increases the risk that misconduct is detected earlier and pursued more aggressively.

The press release also ties the initiative to FinCEN’s Anti-Money Laundering and Countering the Financing of Terrorism National Priorities and to a wider Trump administration effort against fraud, waste and abuse in federal payments. Coordination with the FBI and HHS-OIG reinforces that this is not a standalone policy statement. It is part of a broader enforcement alignment across Treasury, law enforcement and health care oversight bodies.

From an SEO and compliance perspective, the most important takeaway is that FinCEN is explicitly linking Medicare fraud, Medicaid fraud, money laundering, organised crime and whistleblower enforcement in one coordinated message. Financial institutions, health care providers, payments businesses and compliance professionals should treat this as a signal to review fraud monitoring, suspicious activity escalation and customer due diligence around health care-related accounts. The enforcement direction is clear: health care fraud is being treated as a financial crime priority, not a niche benefits issue.

Read the press release here.